Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alsenz

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Behring Institute Mitteilungen|July 1, 1989
The acquired C1-INH deficiencies with autoantibodies (AAE type II)J Alsenz, M Loos
Journal of Immunological Methods|April 22, 1988
A rapid and simple ELISA for the determination of duplicate monoclonal antibodies during epitope analysis of antigens and its application to the study of C1(-)-INHJ Alsenz, M Loos
Journal of Immunological Methods|January 26, 1987
Simplified methods for the purification, quantitation, and functional estimation of human complement C-1-inhibitor (C-1-INH) with a monoclonal anti-C-1-INH antibodyJ Alsenz, M Loos
Pharmaceutical Research|November 14, 1997
Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulationsA Braun, J Alsenz
Pharmaceutical Research|May 1, 1998
Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayersJ Alsenz, H Steffen, R Alex
The New England Journal of Medicine|May 28, 1987
Autoantibody-mediated acquired deficiency of C1 inhibitorJ Alsenz, K Bork, M Loos
Current Topics in Microbiology and Immunology|January 1, 1990
Molecular aspects of C3 interactions and structural/functional analysis of C3 from different speciesJ D Becherer, J Alsenz, J D Lambris
Wiener Klinische Wochenschrift|March 1, 1985
[Localization of functionally important areas of the regulator protein factor H using monoclonal antibodies]T F Schulz, J Alsenz, M P Dierich
Pharmaceutical Research|November 14, 1997
Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic miceA Braun, L Kwee, M A Labow, et al.
The Journal of Clinical Investigation|June 1, 1989
Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodiesJ Alsenz, J D Lambris, K Bork, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Behring Institute Mitteilungen|July 1, 1989
The acquired C1-INH deficiencies with autoantibodies (AAE type II)J Alsenz, M Loos
Journal of Immunological Methods|April 22, 1988
A rapid and simple ELISA for the determination of duplicate monoclonal antibodies during epitope analysis of antigens and its application to the study of C1(-)-INHJ Alsenz, M Loos
Journal of Immunological Methods|January 26, 1987
Simplified methods for the purification, quantitation, and functional estimation of human complement C-1-inhibitor (C-1-INH) with a monoclonal anti-C-1-INH antibodyJ Alsenz, M Loos
Pharmaceutical Research|November 14, 1997
Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulationsA Braun, J Alsenz
Pharmaceutical Research|May 1, 1998
Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayersJ Alsenz, H Steffen, R Alex
The New England Journal of Medicine|May 28, 1987
Autoantibody-mediated acquired deficiency of C1 inhibitorJ Alsenz, K Bork, M Loos
Current Topics in Microbiology and Immunology|January 1, 1990
Molecular aspects of C3 interactions and structural/functional analysis of C3 from different speciesJ D Becherer, J Alsenz, J D Lambris
Wiener Klinische Wochenschrift|March 1, 1985
[Localization of functionally important areas of the regulator protein factor H using monoclonal antibodies]T F Schulz, J Alsenz, M P Dierich
Pharmaceutical Research|November 14, 1997
Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic miceA Braun, L Kwee, M A Labow, et al.
The Journal of Clinical Investigation|June 1, 1989
Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodiesJ Alsenz, J D Lambris, K Bork, et al.
Pageof 3